pretomanid
Jump to navigation
Jump to search
Indications
- for use in combination with bedaquiline & linezolid for treatment of adults with treatment-resistant pulmonary tuberculosis
Adverse effects
- when use in combination with bedaquiline & linezolid
- peripheral neuropathy), acne, anemia, nausea, vomiting, headache, increased serum transaminases & serum gamma-glutamyltransferase, dyspepsia), rash, ihyperamylasemia, visual impairment, hypoglycemia, diarrhea
More general terms
References
- ↑ FDA News Release. Aug 13, 2019 FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs